Edwards Lifesciences Corporation logo
EWEdwards Lifesciences Corporation

Shares Outstanding: 580.70M

popular:market cap|pe ratio|revenue|price history|total return

The shares outstanding is 580.70M. It is below its 12-month average by 0.70% (584.78M).

Market Cap|Share Buybacks|EPS|All Metrics
Shares Outstanding

EW Shares Outstanding

580.70M

Reported quarterly weighted average share count; no daily interpolation.

-7.81% 5Y
EW Shares Outstanding

EW Average Shares Outstanding Chart

EW Shares Outstanding

EW Current vs Average Shares Outstanding Chart

EW Shares Outstanding Metrics

SHARES OUTSTANDING

580.70M

SHARES OUTSTANDING AVG TTM

584.78M

SHARES OUTSTANDING AVG 3Y

596.81M

SHARES OUTSTANDING AVG 5Y

608.58M

SHARES OUTSTANDING AVG 10Y

624.72M

SHARES OUTSTANDING AVG 15Y

639.04M

SHARES OUTSTANDING AVG 20Y

662.56M

CURRENT VS TTM AVG

-0.70%

CURRENT VS 3Y AVG

-2.70%

CURRENT VS 5Y AVG

-4.58%

CURRENT VS 10Y AVG

-7.05%

CURRENT VS 15Y AVG

-9.13%

CURRENT VS 20Y AVG

-12.35%

Share Structure

Shares Outstanding

584.80M

Float Shares

N/A

Stock Price

$90.78

Market Cap

$52.3B

Quarterly Shares Outstanding History

PeriodWeighted Average SharesQoQ Change
Q1 2026580.70M-0.19%
Q4 2025581.80M-0.67%
Q3 2025585.70M-0.37%
Q2 2025587.90M+0.02%
Q1 2025587.80M-0.46%
Q4 2024590.50M-1.27%
Q3 2024598.10M-1.03%
Q2 2024604.30M+0.03%
Q1 2024604.10M-0.46%
Q4 2023606.90M-0.43%
Q3 2023609.50M-0.13%
Q2 2023610.30M-0.10%
Q1 2023610.90M-0.86%
Q4 2022616.20M-1.33%
Q3 2022624.50M-0.35%
Q2 2022626.70M-0.43%
Q1 2022629.40M-0.41%
Q4 2021632.00M+0.05%
Q3 2021631.70M+0.29%
Q2 2021629.90M-0.22%
Q1 2021631.30M-0.11%
Q4 2020632.00M+0.16%
Q3 2020631.00M+1.72%
Q2 2020620.30M-2.33%
Q1 2020635.10M-0.42%
Q4 2019637.80M+0.24%
Q3 2019636.30M+0.02%
Q2 2019636.20M-0.06%
Q1 2019636.60M+0.00%
Q4 2018636.60M-0.47%
Q3 2018639.60M-0.37%
Q2 2018642.00M-0.51%
Q1 2018645.30M-0.14%
Q4 2017646.20M-0.37%
Q3 2017648.60M+0.23%
Q2 2017647.10M-0.32%
Q1 2017649.20M-0.69%
Q4 2016653.70M-0.09%
Q3 2016654.30M+0.37%
Q2 2016651.90M-0.23%
Q1 2016653.40M-1.27%
Q4 2015661.80M+0.27%
Q3 2015660.00M+0.00%
Q2 2015660.00M-0.27%
Q1 2015661.80M+0.55%
Q4 2014658.20M+1.20%
Q3 2014650.40M+0.93%
Q2 2014644.40M-1.01%
Q1 2014651.00M-2.25%
Q4 2013666.00M-1.68%
Q3 2013677.40M-1.57%
Q2 2013688.20M-1.55%
Q1 2013699.00M-1.10%
Q4 2012706.80M-1.01%
Q3 2012714.00M+0.51%
Q2 2012710.40M+0.34%
Q1 2012708.00M-0.08%
Q4 2011708.60M-0.76%
Q3 2011714.00M-0.83%
Q2 2011720.00M-0.41%
Q1 2011723.00M+6.07%
Q4 2010681.60M-4.46%
Q3 2010713.40M+0.08%
Q2 2010712.80M-0.17%
Q1 2010714.00M+5.50%
Q4 2009676.80M-3.92%
Q3 2009704.40M+0.34%
Q2 2009702.00M+0.00%
Q1 2009702.00M+4.46%
Q4 2008672.00M-5.08%
Q3 2008708.00M-1.99%
Q2 2008722.40M+2.91%
Q1 2008702.00M+2.45%
Q4 2007685.20M-8.49%
Q3 2007748.80M-0.95%
Q2 2007756.00M-0.79%
Q1 2007762.00M+9.11%
Q4 2006698.40M-8.49%
Q3 2006763.20M-0.93%
Q2 2006770.40M-0.62%
Q1 2006775.20M+8.03%
Q4 2005717.60M+0.00%
Q3 2005717.60M-4.17%
Q2 2005748.80M-3.85%
Q1 2005778.80M+8.71%
Q4 2004716.40M-3.86%
Q3 2004745.20M-4.17%
Q2 2004777.60M+8.72%
Q1 2004715.20M+0.85%
Q4 2003709.20M-3.27%
Q3 2003733.20M-0.49%
Q2 2003736.80M+0.82%
Q1 2003730.80M+3.75%
Q4 2002704.40M+0.00%
Q3 2002704.40M-4.55%
Q2 2002738.00M-

Relationship: Market Cap = Shares Outstanding × Stock Price

Key concepts:

  • Float shares: Shares available for public trading
  • Dilution: When new shares are issued, existing shareholders own less
  • Buybacks: Reduce share count, increasing EPS and ownership stake
  • Stock splits: Increase share count but don't change market cap

Shares Outstanding Formula & Definition

Shares Outstanding represents the reported weighted average share count used for per-share metrics. Changes in share count affect EPS and ownership dilution.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Shares Outstanding FAQ

What is the shares outstanding for Edwards Lifesciences Corporation (EW)?
The shares outstanding for EW stock is 580.70M.
What is the TTM average shares outstanding for Edwards Lifesciences Corporation (EW)?
The TTM average shares outstanding for EW stock is 584.78M.
What is the 3Y average shares outstanding for Edwards Lifesciences Corporation (EW)?
The 3Y average shares outstanding for EW stock is 596.81M.
What is the 5Y average shares outstanding for Edwards Lifesciences Corporation (EW)?
The 5Y average shares outstanding for EW stock is 608.58M.
What is the 10Y average shares outstanding for Edwards Lifesciences Corporation (EW)?
The 10Y average shares outstanding for EW stock is 624.72M.
What is the 15Y average shares outstanding for Edwards Lifesciences Corporation (EW)?
The 15Y average shares outstanding for EW stock is 639.04M.
What is the 20Y average shares outstanding for Edwards Lifesciences Corporation (EW)?
The 20Y average shares outstanding for EW stock is 662.56M.

EW Shares Outstanding History

DATESHARES OUTSTANDING
2026-03-31580.70M
2025-12-31581.80M
2025-09-30585.70M
2025-06-30587.90M
2025-03-31587.80M
2024-12-31590.50M
2024-09-30598.10M
2024-06-30604.30M
2024-03-31604.10M
2023-12-31606.90M
2023-09-30609.50M
2023-06-30610.30M
2023-03-31610.90M
2022-12-31616.20M
2022-09-30624.50M
2022-06-30626.70M
2022-03-31629.40M
2021-12-31632.00M
2021-09-30631.70M
2021-06-30629.90M
2021-03-31631.30M
2020-12-31632.00M
2020-09-30631.00M
2020-06-30620.30M
2020-03-31635.10M
2019-12-31637.80M
2019-09-30636.30M
2019-06-30636.20M
2019-03-31636.60M
2018-12-31636.60M
2018-09-30639.60M
2018-06-30642.00M
2018-03-31645.30M
2017-12-31646.20M
2017-09-30648.60M
2017-06-30647.10M
2017-03-31649.20M
2016-12-31653.70M
2016-09-30654.30M
2016-06-30651.90M
2016-03-31653.40M
2015-12-31661.80M
2015-09-30660.00M
2015-06-30660.00M
2015-03-31661.80M
2014-12-31658.20M
2014-09-30650.40M
2014-06-30644.40M
2014-03-31651.00M
2013-12-31666.00M
2013-09-30677.40M
2013-06-30688.20M
2013-03-31699.00M
2012-12-31706.80M
2012-09-30714.00M
2012-06-30710.40M
2012-03-31708.00M
2011-12-31708.60M
2011-09-30714.00M
2011-06-30720.00M
2011-03-31723.00M
2010-12-31681.60M
2010-09-30713.40M
2010-06-30712.80M
2010-03-31714.00M
2009-12-31676.80M
2009-09-30704.40M
2009-06-30702.00M
2009-03-31702.00M
2008-12-31672.00M
2008-09-30708.00M
2008-06-30722.40M
2008-03-31702.00M
2007-12-31685.20M
2007-09-30748.80M
2007-06-30756.00M
2007-03-31762.00M
2006-12-31698.40M
2006-09-30763.20M
2006-06-30770.40M
2006-03-31775.20M
2005-12-31717.60M
2005-09-30717.60M
2005-06-30748.80M
2005-03-31778.80M
2004-12-31716.40M
2004-09-30745.20M
2004-06-30777.60M
2004-03-31715.20M
2003-12-31709.20M
2003-09-30733.20M
2003-06-30736.80M
2003-03-31730.80M
2002-12-31704.40M
2002-09-30704.40M
2002-06-30738.00M

Related Metrics

Market CapShare BuybacksEPSAll Metrics

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Irvine, CA
15,800 employees
www.edwards.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian
View full financials